(Q85502004)
Statements
Sorafenib suppresses the rapid progress of hepatocellular carcinoma after insufficient radiofrequency ablation therapy: an experiment in vivo (English)
Ming Xu
Xiao-hua Xie
Xiao-yan Xie
Zuo-feng Xu
Guang-jian Liu
Yan-ling Zheng
Guang-liang Huang
Shu-guang Zheng
21 November 2012